Chronic hepatitis in interferon-γ transgenic mice is associated with elevated CPP32-like activity and interleukin-1β-converting enzyme activity suppression

Japanese Journal of Pharmacology

Volumn 79, Issue 3, 1999, Pages 289-294

  Okamoto, Toshihiro ^a   Nakano, Yoshihisa ^a   Yamakawa, Tomio ^a   Hara, Kaoru ^a   Yamamura, Ken Ichi ^b   Hino, Okio ^c  

^a Nippon Chemiphar Co Ltd   (Japan)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^c CANCER INSTITUTE   (Japan)

Author keywords

Chronic hepatitis; CPP32; Interleukin 1 converting enzyme; Liver; Transgenic mouse

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CASPASE 3; CASPASE INHIBITOR; GAMMA INTERFERON; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 1BETA CONVERTING ENZYME INHIBITOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHRONIC HEPATITIS; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; LIVER; LIVER CELL; MOUSE; NONHUMAN; TRANSGENIC MOUSE;

EID: 0032919237     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.79.289     Document Type: Article

References (22)

1. Tiegs G, Wolter M and Wendel A: Tumor necrosis factor is a terminal mediator in D-galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 38, 627-631 (1989)
2. Tiegs G, Hentschel J and Wendel A: A T cell-dependent experimental liver injury in mice induced by concanavalin A. J Clin Invest 90, 196-203 (1992)
3. Toyonaga T, Hino O, Sugai S, Wakasugi S, Abe K, Shichiri M and Yamamura KI: Chronic active hepatitis in transgenic mice expressing interferon-γ in the liver. Proc Natl Acad Sci USA 91, 614-618 (1994)
4. Okamoto T, Yamakawa T, Yamamura K and Hino O: Induction of Fas ligand and Fas antigen mRNA expressions in interferon-γ transgenic mouse liver. Jpn J Pharmacol 78, 233-235 (1997)
5. Nagata S: Apoptosis by death factor. Cell 88, 355-365 (1997)
6. Rodriguez I, Matsuura K, Ody C, Nagata S and Vassalli P: Systemic injection of a tripeptide inhibits the intracellular activation of CPP32-like proteases in vivo and fully protects mice against Fas-mediated fulminant liver destruction and death. J Exp Med 184, 2067-2072
7. Inayat-Hussain SH, Couet C, Cohen GM and Cain K: Processing/activation of CPP32-like proteases is involved in transforming growth factor β1-induced apoptosis in rat hepatocytes. Hepatology 25, 1516-1526 (1997)
8. Karmen A, Wroblewski F and LaDue JS: Transaminase activity in human blood. J Clin Invest 34, 126-133 (1955)
9. Okamoto T, Mitsuhashi M, Fujita I, Sindhu RK and Kikkawa Y: Induction of cytochrome P450 1A1 and 1A2 by hyperoxia. Biochem Biophys Res Commun 197, 878-885 (1993)
10. Okamoto T, Furuya M, Yamakawa T, Yamamura K-I and Hino O: TNF-α gene expression in the liver of the IFN-γ transgenic mouse with chronic active hepatitis. Biochem Biophys Res Commun 226, 762-768 (1996)
11. Dveksler GS, Basile AA and Dieffenbach CW: Analysis of gene expression. Use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. PCR Methods Appl 1, 283-285 (1992)
12. Pietsh K, Ehlers S and Jacobs E: Cytokine gene expression in the lungs of BALB/c mice during primary and secondary intranasal infection with mycoplasma pneumoniae. Microbiology 140, 2043-2048 (1994)
13. Baecher-Allan CM and Barth RK: PCR analysis of cytokine induction profiles associated with mouse strain variation in susceptibility to pulmonary flbrosis. Resio Immunol 5, 207-217 (1993)
14. Juan TS-C, McNiece JK, Jenkins NA, Gilbert DJ, Copeland NG and Fletcher FA: Molecular characterization of mouse and rat CPP32β gene encoding a cysteine protease resembling interleukin-1β converting enzyme and CED-3. Oncogene 13, 749-755 (1996)
15. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG and Wendel A: Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146, 1220-1234 (1995)
16. Mizuhara H, Uno M, Seki N, Yamashita M, Yamaoka M, Ogawa T, Kaneda K, Fujii T, Senoh H and Fujiwara H: Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestation of hepatitis. Hepatology 23, 1608-1615 (1996)
17. Okamoto T, Kobayashi T, Tsuzuike N and Hara K: Induction of CPP32-like activity and inhibition of interleukin 1β converting enzyme activity in the liver of a mouse concanavalin A-induced hepatitis model. Jpn J Pharmacol 77, 257-259 (1998)
18. Okamoto T and Kobayashi T: Effects of concanavalin A on cytokine mRNA expression in mouse liver. Jpn J Pharmacol 75, 199-201 (1997)
19. Samanta H, Engel DA, Chao HM, Thankur A, Garcia-Blanco MA and Lengyel P: Interferons as gene activators. J Biol Chem 261, 11849-11858 (1986)
20. Tinsborg S, Zetterstrom M, Alheim K, Hasanvan H, Schultzberg M and Bartfai T: Regionally specific inhibition of ICE mRNA and enzyme activity in the rat brain and adrenal gland by LPS. Brain Res 712, 153-158 (1996)
21. Tingsborg S, Ziolkowska M, Zetterstrom M, Hasanvan H and Bartfai T: Regulation of ICE activity and ICE isoforms by LPS. Mol Psychiatry 2, 122-124 (1997)
22. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T-T, Yu VL, and Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376, 37-43 (1995)